A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms. (Q44120368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Angela J Dean

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

James Bell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

David J Mascord

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Macdonald J Christie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

Journal of Affective Disorders

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

85-90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

Benzodiazepine withdrawal: outcome in 50 patients

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Fluoxetine Addition to Methadone in Addicts: Pharmacokinetic Aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Psychiatric and substance use comorbidity among treatment-seeking opioid abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

The use of antidepressants among injecting drug users in Sydney, Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

A meta-analysis of fluoxetine outcome in the treatment of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Imipramine as Treatment for Depression in Addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Anxiety or depression during withdrawal of hypnotic treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Mood state of heroin-dependent persons undergoing methadone detoxification.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Placebos, active control groups, and the unpredictability paradox

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Antidepressant prescribing practices of outpatient psychiatrists.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

A brief self-report depression measure assessing mood state and social impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Baseline characteristics of 10-day placebo washout responders in antidepressant trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Personality and demographic characteristics associated with the prescribing of psychoactive medications for methadone maintenance patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Side effects and the "blindability" of clinical drug trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900419-0

7 January 2021

10.1016/S0165-0327(01)00419-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204321%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference